title: Uterosacral ligament vaginal vault suspension using delayed absorbable monofilament suture.
abstract: OBJECTIVE
  We investigated the incidence of suture complications and recurrent prolapse following uterosacral ligament suspension (USLS) using delayed absorbable polyglyconate monofilament suture (Maxon).
  
  
  METHODS
  We reviewed the medical records of subjects who underwent vaginal USLS using polyglyconate suture. Primary outcomes were suture complications and anatomic failures defined as recurrent apical prolapse stage 1 or greater. Secondary outcomes were subjective failures and reoperation rate for apical prolapse.
  
  
  RESULTS
  Fifty-seven out of 68 subjects who underwent USLS with polyglyconate suture over the study period were included in analysis. At median follow-up of 12 months, 3.5% had suture complications. The anatomic and symptomatic failure rate was 7%. One subject underwent repeat surgery for prolapse.
  
  
  CONCLUSIONS
  Suture complications are uncommon using polyglyconate suture for USLS, and failure rates are low. This is in comparison to a 44.6% suture erosion rate with permanent suture reported by our institution using the same surgical technique.
authors.affiliation: Division of Female Pelvic Medicine and Reconstructive Surgery, Harbor-UCLA Medical Center, 1000 W. Carson St., Bldg D3, Box 489, Torrance, CA 90509, USA. micheline.wong@gmail.com
authors.forename: Micheline J
authors.initials: MJ
authors.lastname: Wong
authors.forename: Azadeh
authors.initials: A
authors.lastname: Rezvan
authors.forename: Narender N
authors.initials: NN
authors.lastname: Bhatia
authors.forename: Tajnoos
authors.initials: T
authors.lastname: Yazdany
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D005549:Foreign-Body Reaction / Q000209:etiology*; D006801:Humans; D008022:Ligaments / Q000601:surgery; D008875:Middle Aged; D056887:Pelvic Organ Prolapse / Q000473:pathology* / Q000601:surgery*; D011108:Polymers / Q000009:adverse effects; D011183:Postoperative Complications / Q000209:etiology*; D012008:Recurrence; D012720:Severity of Illness Index; D013537:Sutures / Q000009:adverse effects*; D017211:Treatment Failure; D053201:Urinary Bladder, Overactive / Q000209:etiology; D014550:Urinary Incontinence, Stress / Q000209:etiology; D014621:Vagina / Q000473:pathology*
chemical_list: D011108:Polymers; C046409:polyglyconate